Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123133152 | 12313315 | 2 | F | 201603 | 20160720 | 20160428 | 20160805 | PER | US-PFIZER INC-2016197319 | PFIZER | 73.00 | YR | F | Y | 48.53000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123133152 | 12313315 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 100 MG, 1X/DAY | U | 20235 | 100 | MG | CAPSULE, HARD | QD | |||||
| 123133152 | 12313315 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | U | 20235 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123133152 | 12313315 | 1 | Anxiety |
| 123133152 | 12313315 | 2 | Depression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123133152 | 12313315 | Drug intolerance | |
| 123133152 | 12313315 | Product use issue | |
| 123133152 | 12313315 | Sedation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123133152 | 12313315 | 1 | 2004 | 0 |